Navigation Links
A New Drug To Address Canine Obesity

Food And Drug Administration (FDA) has come up with a solution to deal with the growing epidemic of canine obesity in the United States.//

Pfizer, the drug manufacturer has made a new weight-reducing drug named Slentrol to control obesity in dogs.

Nowadays as the owners work late hours, the dogs lounge around all day and the lack of exercise coupled with the fatty food they get to eat makes them obese.

“This is a welcome addition to animal therapies, because dog obesity appears to be increasing,” said Dr. Stephen Sundlof, director of the Center for Veterinary Medicine.

Obese dogs are those that are 20 % overweight. Approx. 5 % of dogs in the US are obese, and another 20 to 30 percent are overweight, according to the drug agency.

The drug is expected to target four million American obese dogs that are potential candidates for this therapy, which would cost $1 to $2 a day.

“This is not a passport to abandon exercise or diets,” said George J. Fennell, Pfizer’s vice-president in the United States for companion animal health. “The drug would be a big help for dog owners who find it difficult to cut back on doggy treats.”

“You hear pet owners say: ‘The dog really wags his tail when I give him a treat. It’s hard to hold back,’ ” Mr. Fennell said.

Veterinarians complain that the pet owners overindulge in feeding and spoil them with treats, which makes them pretty heavy.

Slentrol is in a liquid form and can be added to a dog’s food or given directly in its mouth. The duration of treatment will be decided depending on the amount of weight that has to be lost. Results of clinical studies show that dogs on Slentrol lost roughly about 3 percent of their weight a month.

Obese dogs often suffer from cardiovascular problems, diabetes, torn ligaments, sores on their elbows, hip and back problems, and arthritis.

Source-Medndia
PRI
'"/>




Page: 1

Related medicine news :

1. Imbalance In Gender Ratio Addressed By Religious Leaders
2. 93 Year Old Widow, Suffering From Dementia Dies After the Ambulance Dropped Her at a Wrong Address
3. NGOs and Various Groups Come Together To Address the Issues on AIDS
4. Budhias Medical Report Fails to Address Long Term Health Issues
5. Ontario Addresses Shortage of Transplant Organs
6. Blood Safety, Supply, and Innovations Addressed at Conference
7. Special Section of JCS Addresses Vascular Anomalies
8. Patient Safety Not Addressed by NHS
9. President’s Address on the ‘Tele-Radiology’ Set Up of Krst
10. New Guidelines to Address Growing Obesity Epidemic
11. NASA Gets Ready To Address Tough Questions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... 2017 , ... The National Campaign to Prevent Teen ... to Contraception for Women Servicemembers and Dependents Act of 2017. The bill, introduced ... to ensure that all members of the Armed Forces receive high quality education ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of ... rating of “A” and its outlook as “stable.” At the same time, the ratings ... fallen in recent years, dip below “capital adequacy” thresholds required for its strong rating. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... or hERG liability could substantially improve drug safety and minimize the cost of ... for validating ion channel inhibition using cell lines and for cardiac toxicity using ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... for the North East region. Côté has 20+ years of experience within the ... Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017 The Global ... Forecast to 2022 report has covered and analysed the potential ... information on market size, shares and growth factors. The report ... challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major ...
(Date:4/19/2017)... April 19, 2017 ... immune response in pets such as canine, avian ... of various types such as Attenuated Live Vaccines, ... DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines ... or bacteria, which have been weakend under laboratory ...
Breaking Medicine Technology: